PMC:7105881 / 9034-9902 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"366","span":{"begin":447,"end":450},"obj":"Gene"},{"id":"367","span":{"begin":492,"end":495},"obj":"Gene"},{"id":"368","span":{"begin":2,"end":9},"obj":"Species"},{"id":"369","span":{"begin":11,"end":20},"obj":"Species"},{"id":"370","span":{"begin":158,"end":166},"obj":"Species"},{"id":"371","span":{"begin":235,"end":241},"obj":"Species"},{"id":"372","span":{"begin":675,"end":683},"obj":"Species"},{"id":"373","span":{"begin":699,"end":707},"obj":"Species"},{"id":"374","span":{"begin":709,"end":718},"obj":"Species"},{"id":"375","span":{"begin":729,"end":734},"obj":"Species"},{"id":"376","span":{"begin":738,"end":743},"obj":"Species"},{"id":"377","span":{"begin":810,"end":815},"obj":"Species"},{"id":"378","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"379","span":{"begin":210,"end":218},"obj":"Disease"},{"id":"380","span":{"begin":268,"end":274},"obj":"Disease"},{"id":"381","span":{"begin":816,"end":825},"obj":"Disease"}],"attributes":[{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"Gene:246329"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"Gene:6717"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"Tax:2697049"},{"id":"A369","pred":"tao:has_database_id","subj":"369","obj":"Tax:2697049"},{"id":"A370","pred":"tao:has_database_id","subj":"370","obj":"Tax:9606"},{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"Tax:9606"},{"id":"A372","pred":"tao:has_database_id","subj":"372","obj":"Tax:1335626"},{"id":"A373","pred":"tao:has_database_id","subj":"373","obj":"Tax:694009"},{"id":"A374","pred":"tao:has_database_id","subj":"374","obj":"Tax:2697049"},{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"Tax:9606"},{"id":"A376","pred":"tao:has_database_id","subj":"376","obj":"Tax:9606"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"Tax:9606"},{"id":"A378","pred":"tao:has_database_id","subj":"378","obj":"MESH:D011014"},{"id":"A379","pred":"tao:has_database_id","subj":"379","obj":"MESH:D007239"},{"id":"A380","pred":"tao:has_database_id","subj":"380","obj":"MESH:D003643"},{"id":"A381","pred":"tao:has_database_id","subj":"381","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"T38","span":{"begin":699,"end":707},"obj":"Disease"},{"id":"T39","span":{"begin":816,"end":825},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T83","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T84","span":{"begin":22,"end":25},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T85","span":{"begin":206,"end":209},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T86","span":{"begin":729,"end":734},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T87","span":{"begin":738,"end":743},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T88","span":{"begin":810,"end":815},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":172,"end":181},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"2_test","denotations":[{"id":"32265848-31979013-36511009","span":{"begin":68,"end":72},"obj":"31979013"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"LitCovid-sentences","denotations":[{"id":"T56","span":{"begin":0,"end":94},"obj":"Sentence"},{"id":"T57","span":{"begin":95,"end":659},"obj":"Sentence"},{"id":"T58","span":{"begin":660,"end":868},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T153","span":{"begin":11,"end":20},"obj":"SP_7"},{"id":"T154","span":{"begin":235,"end":241},"obj":"NCBITaxon:9606"},{"id":"T155","span":{"begin":268,"end":274},"obj":"GO:0016265"},{"id":"T156","span":{"begin":675,"end":683},"obj":"SP_9"},{"id":"T157","span":{"begin":699,"end":707},"obj":"SP_10"},{"id":"T158","span":{"begin":709,"end":718},"obj":"SP_7"},{"id":"T159","span":{"begin":729,"end":734},"obj":"SP_6;NCBITaxon:9606"},{"id":"T160","span":{"begin":738,"end":743},"obj":"SP_6;NCBITaxon:9606"},{"id":"T161","span":{"begin":810,"end":815},"obj":"SP_6;NCBITaxon:9606"},{"id":"T56652","span":{"begin":11,"end":20},"obj":"SP_7"},{"id":"T10254","span":{"begin":235,"end":241},"obj":"NCBITaxon:9606"},{"id":"T74012","span":{"begin":268,"end":274},"obj":"GO:0016265"},{"id":"T6966","span":{"begin":675,"end":683},"obj":"SP_9"},{"id":"T27335","span":{"begin":699,"end":707},"obj":"SP_10"},{"id":"T62677","span":{"begin":709,"end":718},"obj":"SP_7"},{"id":"T63172","span":{"begin":729,"end":734},"obj":"SP_6;NCBITaxon:9606"},{"id":"T12710","span":{"begin":738,"end":743},"obj":"SP_6;NCBITaxon:9606"},{"id":"T46923","span":{"begin":810,"end":815},"obj":"SP_6;NCBITaxon:9606"}],"text":"A new CoV, 2019-nCoV, has caught worldwide attention (Liu and Saif, 2020; Zhang et al., 2020). It was first identified in Wuhan, China in December 2019, from patients with pneumonia (Zhu et al., 2020), and has infected more than 70000 people globally, including 2,009 deaths (∼2.7% fatality rate), as of February 19, 2020, particularly in China, and the other parts of the world, including Australia, Japan, Malaysia, Singapore, South Korea, Viet Nam, Cambodia, Philippines, Thailand, Nepal, Sri Lanka, India, United States, Canada, France, Finland, Germany, Italy, Russian Federation, Spain, Sweden, United Kingdom, Belgium, Egypt, and United Arab Emirates3. Different from MERS-CoV but similar to SARS-CoV, 2019-nCoV can cause human-to-human transmission, and its intermediate host that leads to the current human infection and outbreak is still under investigation."}